Plus, pharmacy groups famed for opioid bankruptcies join forces and the mysterious Deutsche Bank employee making more than its CEO ...

Mallinckrodt Pharmaceuticals and Endo have agreed to combine in a nearly $7bn deal after the pair emerged from bankruptcy processes linked to liabilities over the US opioid crisis.

Welcome to the Winter 2025 issue of “FCA Enforcement & Compliance Digest,” our quarterly newsletter in which we compile essential updates on ...

Prior to 60 Minutes' March 9, 2025 broadcast, which featured correspondent Cecilia Vega's report on the Purdue Pharma ...

The opioid epidemic is one of the most devastating public health crises in American history. Sadly, the crisis was a man-made disaster fueled by corporate greed, deception and negligence. As we ...

Levy had left Ropes to serve initially as First Assistant US Attorney in January 2022. He ended up leading the office and its ...

According to a McKinsey report, exports rose at 9 per cent annually in ... reinforcing India's role in global pharma supply chains. However, the sector faces disruptions, and automation and new ...

Purdue University--Main Campus, a public institution, offers online labs, and all of the online classes are recorded and archived so students can access lecture material at their convenience ...

According to McKinsey & Company’s latest report, this growth is driven by pharma exports growing faster than the global average, is at a tipping point: emerging trends in Indian and global ...

According to strategy and consulting firm McKinsey, the anticipated $100 billion to $150 billion in new revenue from GenAI-driven offerings has also been slow to materialise. Additionally, if the ...

For the first time ever, some teams will be left out of the Big Ten Tournament. Purdue has already secured its spot in the event, along with five other teams. Purdue's goal this year wasn't to ...

Dr. Reddy’s Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India's largest drugmaker, declined by 3.2% to Rs 1,647.35, becoming the top loser on the BSE ...